Page last updated: 2024-10-28

hexamethonium and Cardiovascular Diseases

hexamethonium has been researched along with Cardiovascular Diseases in 4 studies

Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.

Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.

Research Excerpts

ExcerptRelevanceReference
"Lead is considered a causative factor for hypertension and other cardiovascular diseases."3.85Sub-chronic lead exposure produces β ( Alonso, MJ; Fioresi, M; Salaices, M; Simões, MR; Toscano, CM; Vassallo, DV, 2017)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19902 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Toscano, CM1
Simões, MR1
Alonso, MJ1
Salaices, M1
Vassallo, DV1
Fioresi, M1
Gulliford, M1
Charlton, J1
Bhattarai, N1
Rudisill, C1
PACIFICO, A1
AUBERT, H1
GAVRILESCU, S1

Other Studies

4 other studies available for hexamethonium and Cardiovascular Diseases

ArticleYear
Sub-chronic lead exposure produces β
    Life sciences, 2017, Jul-01, Volume: 180

    Topics: Animals; Arterial Pressure; Cardiovascular Diseases; Down-Regulation; Heart Rate; Hexamethonium; Hyp

2017
Social and material deprivation and the cost-effectiveness of an intervention to promote physical activity: cohort study and Markov model.
    Journal of public health (Oxford, England), 2014, Volume: 36, Issue:4

    Topics: Adult; Cardiovascular Diseases; Chronic Disease; Cohort Studies; Cost-Benefit Analysis; Cultural Dep

2014
[Limitations and possibilities of hexamethonium in cardiovascular pathology].
    La Riforma medica, 1956, Apr-07, Volume: 70, Issue:14

    Topics: Cardiovascular Agents; Cardiovascular Diseases; Coronary Disease; Hexamethonium; Humans; Muscle Rela

1956
[Hexamethonium bromide in therapy of some cardiovascular diseases].
    Medicina interna, 1956, Volume: 8, Issue:8

    Topics: Cardiovascular Diseases; Hexamethonium; Hexamethonium Compounds; Humans

1956